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Abstract
Objectives To determine the influence of lowering iodinated
contrast concentration on confidence of interventional radiol-
ogists in diagnosing and treating lesions during endovascular
interventions in patients with symptomatic peripheral arterial
disease (PAD).
Methods A randomized controlled non-inferiority trial was
performed in 60 patients. Intervention was performed with
contrast concentrations (in mg of iodine per mL, mgI/mL) of
300 (standard), 240, or 140 mgI/mL. Primary outcome was
confidence (score 0-100 %) of radiologists in diagnosing and
treating arterial lesions. Secondary outcomes were procedural
iodine load and image quality (i.e. non-diagnostic, limited,
diagnostic, exemplary).
Results Median confidence scores in diagnosing lesions were
100 % (range 81-100 %) for the 300 group (n=21), 100 %
(range 82-100%) for the 240 group (n=19), and 100% (range
91-100 %) for the 140 group (n=20) (both p=1.00 compared
to the 300 group). Median scores for treating lesions in the 240
and 140 groups, 100 % (range 79-100%, p=0.40), and 100 %
(range 63-100 %, p=0.25), respectively, were not lower com-
pared to the 300 group (median 100 %, range 78-100 %).
Procedural iodine load was lower in the 240 (24.3±7.6 g,
p=0.022) and 140 groups (17.8±5.6 g, p<0.001) compared
to the 300 group (29.7±6.3 g). Image quality was diagnostic
for all groups.
Conclusion Using iodine contrast of 140 mgI/mL for diagno-
sis and interventions in PAD patients significantly reduces
administered iodine load without compromising image quali-
ty. Future use of lower iodine dose is recommended.
Key Points
• Lower iodinated contrast concentration during
endovascular intervention does not decrease radiologist’s
confidence.
• Image quality of standardized angiographies remains diag-
nostic using 140 mgI/mL iodinated contrast concentration.
• Iodine load during intervention can be decreased by >40 %
when using 140 mgI/mL.
• Implementing the use of a lower iodinated contrast concen-
tration will reduce the costs of the procedure.
Keywords Peripheral arterial disease . Intermittent
claudication . Critical limb ischemia . Contrast media .
Angiography
Introduction
The use of intravascular iodinated contrast media carries a risk
of contrast-induced nephropathy (CIN), which is associated
with an increase in morbidity and mortality [1]. CIN can be
defined as an impairment in renal function, i.e. an increase in
serum creatinine by more than 25 % or 44 μmol/L, occurring
within 3 days following intravascular contrast administration
without an alternative aetiology [2]. The incidence of CIN is
low in patients with a normal renal function, but can be as high
as 25 % in patients with impaired renal function, especially
secondary to diabetes mellitus [3].
Presentation of study This randomized controlled trial has been
presented at CIRSE in September 2015.
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Patients with intermittent claudication (IC) or critical limb
ischemia (CLI) due to peripheral arterial disease (PAD), often
have several risk factors for developing CIN after an
endovascular intervention. To prevent CIN in high risk pa-
tients, hydration using saline or bicarbonate is recommended,
but based on the consensus of experts and small or retrospec-
tive studies [1]. Other strategies, such as N-acetylcysteine [4]
or statin pretreatment [5], are also accepted approaches to
prevention of CIN, though not evidence-based.
In the 1980s and 1990s, many studies were performed on
finding the right contrast medium and concentration [6, 7]. In
1992, Ugolotti et al showed that with concentrations of
150mg iodine per mL (mgI/mL) adequate images of the lower
limb could be acquired [8]. With improved technical specifi-
cations for angiographic equipment achieved during the last
few decades, such as a higher image resolution, lowering the
iodinated contrast concentration might be an appropriate way
to prevent CIN, especially since a higher volume use of iodin-
ated contrast is associated with the risk of CIN [9]. Currently,
many interventional radiologists use a contrast concentration
of about 300 mg iodine per mL (mgI/mL) for lower limb
angiography and interventions. Lowering this concentration
might compromise the image quality, especially in patients
with CLI and multi-level disease.
The aim of this study was to compare the confidence of
interventional radiologists in performing an endovascular in-
tervention in patients with PAD between three different con-
centrations of iodinated contrast.
Materials and methods
This trial was reported according to the extended
Consolidated Standards of Reporting Trials (CONSORT)
2010 statement [10]. This trial was registered in advance at
www.trialregister.nl (trial identification NTR3406). Ethical
approval was obtained from the local ethics committee.
Trial design
The trial was designed as a prospective, multicentre, three-
armed, double-blind randomized controlled non-inferiority
trial and was carried out in two hospitals.
For the three arms, iohexol 300 mgI/mL, considered the
control group, iohexol 240 mgI/mL, and iohexol 140 mgI/
mL contrast concentrations were used.
Participants
All patients (≥18 years) presenting at the vascular surgery
outpatient clinic referred for digital subtraction angiography
(DSA) were eligible for this study. In all patients, vascular
status was evaluated by duplex ultrasound before they were
referred for intervention.
Inclusion criteria were:
– IC (Fontaine stage II) or CLI (Fontaine stage III or IV)
due to PAD
– Ankle-brachial pressure index (ABPI) <0.90, or drop in
ABPI >0.15 after exercise, or toe-brachial pressure index
(TBPI) <0.70
– Duration of complaints>2 weeks
– Scheduled for DSA with anterograde femoral artery
puncture
– Written informed consent
Exclusion criteria were:
– renal failure; serum creatinine>130 μmol/L
– inability to give informed consent
– participation in another study
Baseline characteristics of the included patients were record-
ed using a standardized case record form and comprised patient
demographics, risk factors for atherosclerosis, history of coro-
nary artery disease, transient ischemic attack (TIA) or stroke,
family history of cardiovascular disease, and renal failure.
Patient characteristics
Sixty consecutive patients were included between April 2012
and July 2014, of which 21, 19, and 20 were randomly allo-
cated to respectively the control, 240, and 140 groups. The
mean age of all patients was 70.8±9.5 years, 38 (63 %) were
male, 26 (43 %) had diabetes, and 35 (58 %) had CLI
(Table 1).
Interventions
Endovascular interventions were performed by interventional
radiologists who had experience in interventional radiology
varying between 1 and 25 years. In total, seven interventional
radiologists performed procedures for this trial.
Diagnostic DSA and intervention were done with three
different doses of contrast media. In the control group, iohexol
300 was used, and in the experimental groups, iohexol 240
and iohexol 140 contrast (respectively, Omnipaque 300, 240,
and 140 mgI/mL, Amersham Health, Buckinghamshire, UK).
After antegrade puncture of the common femoral artery,
angiography was performed according to a standardized pro-
cedure. Angiography of the superficial femoral artery and
popliteal artery was done through a 5 French endhole catheter.
Using a contrast power injector, 10 mL of contrast was
injected at a rate of 5 mL/s, and an anteroposterior angiogra-
phy was made. The catheter tip was then placed in the
Eur Radiol (2016) 26:2446–2454 2447
popliteal artery at the level of the knee joint. Standard projec-
tion images of the crural arteries, i.e. anteroposterior and
oblique projections, and one lateral projection of the foot,
were made with 10 mL of contrast at a rate of 3 mL/s. When
femoropopliteal or crural arterial segments were not in the
field of view during the first acquisition, a second, more distal,
acquisition was made.
Arterial recanalisation was performed according to stan-
dard procedures, i.e. initial balloon angioplasty, and only in
residual significant stenosis or dissection a stent was placed.
At any time during the procedure, the interventional radiolo-
gist had the ability to change to the standard concentration
(300 mgI/mL), if image quality was judged too poor for ade-
quate diagnostic evaluation or intervention.
Primary outcomes
Primary outcomes were the confidence score in diagnosing
arterial stenosis or occlusion and the confidence in treating
arterial stenosis or occlusion. The confidence scores were
assessed using a visual analogue scale (VAS) ranging between
0 % confidence and 100 % confidence. These outcomes were
scored by the interventional radiologist performing the
procedure.
Secondary outcomes
Secondary outcomes were volume of contrast used during
intervention, image quality of the standardized angiographies,
interobserver agreement in assessing arterial lesions, contrast-
to-noise ratio (CNR), and the pain score of the patient during
contrast injection.
Image quali ty was assessed separately for the
femoropopliteal, crural, and foot angiographies by three inter-
ventional radiologists (radiologist performing the procedure,
SS, and DDB) according to the Radlex® image quality scoring
criteria [11]: [0] non-diagnostic (unacceptable for diagnostic
purposes); (1) limited (acceptable, with some technical defects
Table 1 Baseline characteristics
Total 300 group
(control)
240 group 140 group
No. of patients 60 21 19 20
Age, years (SD) 70.8 (9.5) 73.1 (7.6) 70.2 (12.4) 68.8 (8.0)
Male sex (%) 38 (63) 10 (48) 15 (79) 13 (65)
BMI, kg/m2 (SD) 25.9 (6.5) 26.4 (7.2) 25.1 (3.7) 26.2 (8.0)
Diabetes (%) 26 (43) 9 (43) 9 (47) 8 (40)
Hypertension (%) 51 (85) 16 (76) 17 (89) 18 (90)
Hyperlipidemia (%)
No 18 (30) 4 (19) 6 (32) 8 (40)
Yes 19 (32) 6 (29) 9 (47) 4 (20)
Unknown, statin use 16 (27) 7 (33) 3 (16) 6 (30)
Unknown 7 (12) 4 (19) 1 (5) 2 (10)
Smoking (%)
Current 29 (48) 10 (48) 7 (37) 12 (60)
Former 5 (8) 2 (9) 2 (11) 1 (5)
Never 26 (43) 9 (43) 10 (53) 7 (35)
CAD (%) 12 (20) 4 (19) 3 (16) 5 (25)
TIA or stroke (%) 12 (20) 3 (14) 3 (16) 6 (30)
Family history of CVD (%) 30 (50) 10 (48) 9 (47) 11 (55)
Previous treatment (%)
Ipsilateral revasc. 16 (27) 4 (19) 8 (42) 4 (20)
Fontaine stage (%)
Fontaine II 25 (42) 9 (43) 8 (42) 8 (40)
Fontaine III 11 (18) 2 (9) 2 (11) 7 (35)
Fontaine IV 24 (40) 10 (48) 9 (47) 5 (25)
ABI, median (IQR) 0.63 (0.50-0.82) 0.57 (0.42-0.77) 0.71 (0.59-0.85) 0.63 (0.50-0.83)
Absolute toe pressure, mmHg (IQR) 42 (16-66) 40 (0-75) 45 (13-64) 52 (18-68)
ABI, ankle brachial pressure index; BMI, body mass index; CAD, coronary artery disease; CVD, cardiovascular disease; IQR, interquartile range; SD,
standard deviation; TIA, transient ischemic attack
2448 Eur Radiol (2016) 26:2446–2454
but still adequate for diagnostic purposes); (2) diagnostic (ac-
ceptable, with no technical defects likely to impair diagnosis);
(3) exemplary (good, most adequate for diagnostic purposes).
For each artery, i.e. superficial femoral artery, popliteal ar-
tery, tibioperoneal trunk, anterior tibial artery, posterior tibial
artery, peroneal artery, plantar artery, and dorsal pedal artery,
two radiologists (SS, DDB; respectively, 1 year and 3 years
experience in interventional radiology) scored whether the
artery was (1) fully patent or stenosis <50 %, (2) stenosis
>50 %, or (3) occluded. Foot arteries were judged as Bnot
assessable^ if distal foot arteries were not visualized at all
due to crural occlusions.






Here, the mean intensity value in the artery (IV artery )
subtracted by the mean intensity value in the adjacent tissue
(IV tissue ) is considered the contrast between the artery and the
tissue. The noise is defined as the standard deviation of the
intensity of the adjacent tissue (SDtissue). These values were
assessed by one observer (SJ), by drawing a region of interest
(ROI) in patent arteries of femoropopliteal, crural, and foot
angiographies, and a ROI in adjacent tissue. The ROI in the
artery was drawn distally from the contrast injection site. All
CNRs were calculated using the DSA images.
The pain score of the patient during contrast injection on a
4-point scale (no, mild, moderate, or severe pain), and volume
of contrast used was recorded by the interventional radiologist
performing the procedure.
Sample size
In a previous study assessing physicians confidence scores,
the mean confidence score for therapeutic decision making
based on DSA in patients with PAD was 8.1±1.4 (standard
deviation, SD) on a scale of 10, with 0 being absolutely un-
certain and 10 being absolutely certain [12]. In our design, the
radiologists were asked to rate confidence on a scale of 0 to
100 %. Therefore, the SD of the confidence score was 14.
Since using a lower iodine concentration would be beneficial
for the patient, we set the boundary for acceptable loss of
confidence in the 240 or 140 group compared to the control
group at 10 %.
To evaluate whether the mean difference (delta) of
maximal 10 % of the 240 or 140 group is not inferior
to the 300 group, with a power of 80 % (Zb=0.842)
and significance level of 0.10 (Za=1.28), and under the
assumption that the SD of the groups would be 14, 18
patients were needed per group. Therefore, 60 patients
were included in total.
Randomization
Randomization was computer-based in a 1:1:1 ratio using
minimization (biased coin randomization). Stratification was
applied for the Fontaine classification (stage II versus stage III
and IV) and presence of diabetes with the coin bias factor set
at 80 %. Randomization was performed by the coordinating
investigator after informed consent was obtained.
Blinding
To ensure that the interventional radiologist was blinded for
the contrast concentration, the coordinating investigator sup-
plied the contrast directly for the power injector and for con-
trast injection by hand. Patients were also blinded to the allo-
cated contrast concentration.
Statistical analysis
The confidence of the interventional radiologist in diagnosing
or in treating arterial stenosis or occlusion of the 240 and 140
groups was compared separately to the control group by a
one-sided Mann-Whitney U test.
The volume of contrast material used in the 240 and 140
groups per patient was compared separately to the control
group by two-sided independent samples t-test.
The interobserver variation in confidence in diagnosing
arterial stenosis or occlusion and in grading imaging quality
was evaluated bymeans of weighted kappa statistics including
95 % confidence interval (95 % CI).
The CNR scores were compared between groups using the
Mann-Whitney U test.
The pain scores during contrast injection were compared
between groups using the Χ2 test.
All analyses were done using SPSS (SPSS 20 Inc.,




Single above the knee interventions were performed in 42
(70 %) patients, single below the knee interventions in eight
(13 %) patients, and both above and below the knee interven-
tions in five (8 %) patients. In five (8 %) patients no interven-
tion was performed. One patient was evaluated for dissection,
which could not be treated endovascularly, in two patients an
occlusion could not be passed with the catheter, and in two
patients no significant stenosis was found (false positive du-
p lex u l t r a sound) . Out of 60 ang iograph ies , 59
femoropopliteal, 53 crural, and 52 lateral foot angiographies
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were available for evaluation by the three observers. One
femoropopliteal angiography was not made since the superfi-
cial femoral artery was proximally occluded. Seven crural and
eight lateral foot angiographies were not made according to the
standard operating procedure, since the tip of the catheter could
not be placed at the level knee joint in the popliteal artery due to
proximal occlusions in five patients, or due to the risk of dis-
section during advancement of the catheter in the artery in one
patient, or since the radiologist refrained from imaging due to
pain complaints during contrast injection in two patients.
In total 68 lesions were treated, of which 66 (97 %) were
technically successful. Revascularization was not successful
in one patient in the control group and one in the 140 group.
Intervention characteristics are listed in Table 2.
Confidence scores
The median confidence score of the radiologist in diagnosing
arterial lesions was 100 % (range 81-100 %) for the control
group. The median confidence scores in the 240 and 140
groups were respectively 100 % (range 82-100 %) and
100 % (range 91-100 %). The confidence scores of the 240
(p=1.00) and 140 group (p=1.00) were not inferior compared
to the control group.
The median confidence score of the radiologist for treating
arterial lesions was 100 % (range 78-100 %) for the control
group. The median scores in the 240 and 140 groups were
respectively 100 % (range 79-100 %) and 100 % (range 63-
100 %). Confidence scores for the 240 and 140 groups were
not inferior compared to the control group, with p-values of
respectively 0.40 and 0.25 (Table 3).
Volume of contrast used
In the control group the interventional radiologist used amean of
99±21 mL of contrast per patient. For the 240 and 140 groups
this was respectively 101±32 mL and 127±40 mL, with p-
values compared with control-group of respectively 0.77 and
0.008. For the control group this resulted in an iodine load per
patient of 29.7±6.3 g, and for the 240 and 140 groups respec-
tively in a load of 24.3±7.6 g and 17.8±5.6 g. The iodine loads
in the 240 and 140 groups were both significantly lower than the
control group, with respective p-values of 0.022 and <0.001. See
Table 4 for the contrast volume and iodine load per group.
Image quality
In all patients, the allocated contrast concentration was used
and was adequate for diagnostic evaluation and intervention in
all patients according to the interventional radiologist
performing the procedure. The radiologist performing the in-
tervention scored one crural acquisition as limited quality in
the control group, and one pedal acquisition as non-diagnostic
and limited quality. One pedal acquisition in the 240 group
was scored as limited quality. In the 140 group, no acquisition
was scored as non-diagnostic or limited quality. For all other
acquisitions, the radiologist performing the procedure scored
the images as diagnostic or exemplary quality (Fig. 1).
For the two radiologists assessing all standardized image
acquisitions, one radiologist scored a pedal acquisition as non-
diagnostic, and two pedal acquisitions as limited quality in the
control-group. In the 240 group, one radiologist scored one
crural angiography and one pedal angiography as limited
quality. Both radiologists scored in the 140 group one pedal
angiography as limited quality. All other angiographies were
either scored as diagnostic or exemplary by both observers.








Number of patients 21 19 20
ATK intervention 14 (67) 13 (68) 15 (75)
BTK intervention 2 (10) 4 (21) 2 (10)
ATK/BTK intervention 3 (14) 0 (0) 2 (10)
No intervention 2 (10) 2 (11) 1 (5)
Total interventions 26 20 22
PTA 15 (58) 11 (55) 15 (68)
PTA+stent 6 (23) 4 (20) 1 (5)
Subintimal angioplasty 3 (11) 4 (20) 3 (13.5)
Subintimal+stent 2 (8) 1 (5) 3 (13.5)
ATK, above the knee (i.e. femoropopliteal arterial segments); BTK, below
the knee; PTA, percutaneous transluminal angioplasty








Confidence in diagnosing arterial lesion in % (range) 100 (81-100) 100 (82-100) 100 (91-100)
p-value* NA 1.0 1.0
Confidence in treating arterial lesions in % (range) 100 (78-100) 100 (79-100) 100 (63-100)
p-value* NA 0.40 0.25
*p-values given are compared to the control group.
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Arterial stenosis or occlusion
A total of 408 out of 480 possible arterial segments were
assessed for patency. As mentioned, due to occlusions, risk
of dissection or pain complaints, 38 arteries could not be im-
aged according to protocol. Furthermore, either the plantar
artery or dorsal pedal artery was not visualized due to proxi-
mal occlusion in 33 patients and were, therefore, scored as












Volume contrast used in ml (SD)T 99 (21) 101 (32) 0.77 127 (40) 0.008
Iodine load in grams (SD)T 29.7 (6.3) 24.3 (7.6) 0.022 17.8 (5.6) <0.001
CNR in median (IQR)M
Total 34.9 (23.0-44.0) 27.2 (17.9-46.6) 0.13 28.0 (17.5-38.7) 0.083
Femoropopliteal 35.0 (28.3-44.2) 44.4 (27.2-50.7) 0.43 34.8 (20.9-62.5) 0.68
Crural 33.9 (22.9-53.8) 28.9 (20.5-61.2) 0.74 25.1 (12.7-37.9) 0.082
Foot 30.8 (13.2-38.9) 13.9 (11.6-19.6) 0.018 25.5 (14.2-35.9) 0.74
Pain during contrast injection* 300 group 240 group 140 group
No 6 11 17
Mild 3 2 2
Moderate 3 5 0
Severe 8 1 0
p-value compared to control X NA 0.055 0.001
CNR, contrast-to-noise ratio; IQR, interquartile range; SD, standard deviation
* In two patients, severity of pain was not assessed, since one patient was sedated. For the other patient pain was not recorded
NA, not assessed
T Compared using two-sided independent samples t test
M Compared using Mann-Whitney U test
X Compared using Χ2 test
Fig. 1 Standardized
angiographic acquisitions using
(A) 300, (B) 240, and (C)
140 mgI/mL
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Bnot assessable^. In one patient, the tibioperoneal trunk was
absent due to anatomical variation. Interobserver agreement
was highest for the control-group with a weighted kappa value
of 0.85 (95%CI, 0.77-0.93). Interobserver agreement was also
excellent for the 240 and 140 groups with weighted kappa
values of respectively 0.82 (95 %CI, 0.72-0.91) and 0.81
(95 %CI, 0.72-0.91). See Table 5 for the interobserver agree-
ment of arterial lesions between both radiologists.
Contrast-to-noise ratio
The CNR was highest for the control-group with a median
ratio of 34.9 (IQR 23.0-44.0) .The CNR for the 240 and 140
groups was 27.2 (IQR 17.9-46.6) and 28.0 (IQR 17.5-38.7),
with respective p-values of 0.13 and 0.083 compared to the
control group. In general, the CNR was highest in the
femoropopliteal arteries and lowest in the pedal arteries. See
Table 4 for the CNR scores.
Pain during contrast injection
During contrast injection 14 (70 %) patients in the control
group had some pain, which was severe in eight (40 %).
Seven (42 %) patients in the 240 group had some pain during
contrast injection. In the 140 group, 17 (89 %) patients had no
pain and two (11 %) patients had mild pain during contrast
injection. The Χ2 test showed no significant difference in pain
scores between the control group and the 240 group (p=
0.055) and a significant difference between the control group
and the 140 group (p=0.001). See Table 4 for the pain scores.
Discussion
This trial showed that the confidence of the interventional
radiologist in diagnosing and treating lower limb arterial ste-
noses or occlusions in patients with PAD in the 240 and 140
groups were not inferior to the control group. The volume of
contrast used in the 140 group was larger than in the control
group and the 240 group. However, the iodine load in the 140
group was significantly lower, with a reduction of 40 % com-
pared to the standard contrast concentration. The image qual-
ity for the femoropopliteal, crural, and foot angiographies was
generally diagnostic or exemplary. Moreover, the CNR
remained relatively high enough for adequate diagnosis and
treatment. Furthermore, patients in the 140 group had signif-
icantly less discomfort during contrast injection.
Implications for clinical practice
As recommended by the updated European Society of
Urogenital Radiology (ESUR) Contrast Media Safety
Committee guidelines, unnecessarily large contrast doses
should be avoided to prevent CIN, and low or iso-osmolar
contrast media should be used [1]. Furthermore, it has been
shown that patients receiving an iodine load (in grams) higher
than their estimated glomerular filtration rate eGFR value (in
mL/min) are significantly more likely to develop CIN [13],
and that in patients with occlusive vascular disease, a higher
cumulative contrast agent exposure was an independent pre-
dictor of renal failure and death [14]. Since the iodine load is
significantly reduced with lower concentrations, and confi-
dence during intervention and image quality remained high,
future lower limb arterial interventions, i.e. distal from the
common femoral artery, in patients with PAD should be per-
formed with the 140 mgI/mL contrast. As this study did not
evaluate the incidence of CIN between groups, future studies
should evaluate the effect of using lower contrast concentra-
tions on the incidence of CIN.
Substitution of iodinated contrast media by carbon dioxide
or gadolinium-based contrast media has been studied exten-
sively. However, for carbon dioxide, studies reported poor
Table 5 Interobserver agreement of arterial lesions per group
CONTROL GROUP
Radiologist 2
Radiologist 1 Patent Stenosis >50 % Occlusion Total
Patent 85 1 2 88
Stenosis >50 % 3 20 0 23
Occlusion 2 3 24 29
Total 90 24 26 140
20 arteries were not assessable.
Kappa=0.85 (95 %CI 0.77-0.93)
240 GROUP
Radiologist 2
Radiologist 1 Patent Stenosis >50 % Occlusion Total
Patent 75 2 2 79
Stenosis >50 % 6 14 2 22
Occlusion 0 1 28 29
Total 81 17 32 130




Radiologist 1 Patent Stenosis >50 % Occlusion Total
Patent 80 1 3 84
Stenosis >50 % 6 20 1 27
Occlusion 1 2 24 27
Total 87 23 28 138
22 arteries were not assessable
Kappa=0.81(95 %CI 0.72-0.91)
Interobserver agreement in scoring standardized angiographies for the
presence of arterial stenosis more than 50 % and occlusion. Radiologist
1, DDB (3 years experience in interventional radiology); Radiologist 2,
SS n1 year experience in interventional radiology)
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visualization of the infrapopliteal arteries and discomfort in
patients [15–21]. Likewise, gadolinium chelates are expensive
and can only be used in low concentrations, resulting in low
attenuation and image quality, especially in distal vessels,
compared to iodinated contrast material [22, 23]. Moreover,
gadolinium does more harm to renal function than equal con-
centrations of iodinated contrast medium [24, 25].
Limitations
Patients with renal insufficiency, i.e. serum creatinine equal to
or higher than 130 μmol/L, were excluded in this trial, since
we anticipated that participating in this trial could result in a
higher contrast load compared to current clinical practice.
However, in hindsight, the iodine load for the patients partic-
ipating in this trial on average was as low as 24.0 mgI, and
especially in the 240 and 140 groups. Since patients with renal
insufficiency have a higher risk for CIN [3] and we excluded
these patients, a relevant patient population was missed. Yet in
our opinion, the results of this trial are also applicable for this
patient population, since we do not expect a correlation be-
tween the outcomes of this trial and renal function.
The initial design of this study included the assessment of
serum creatinine within 3 days following intervention to as-
sess whether CIN had occurred to have direct evidence of the
effect of using lower iodine concentrations on renal function.
However, early in the trial this was removed from protocol,
since patients were reluctant to reappear at the medical centre
for blood withdrawal. We judged that we could refrain from
creatinine assessment without compromising the study ques-
tion, since the sample size calculations of this trial were based
on confidence scores and not on the incidence of CIN. To
evaluate whether there would be a difference between groups
in the incidence of CIN, would have required a considerably
larger study population.
Finally, our study showed that using a lower concentration
leads to a higher injected volume of contrast. One could argue,
therefore, that this could lead to an increased risk of CIN, since
studies already have shown that a larger volume of contrast
increases the risk of CIN [9, 26, 27]. However, as the number
of milligrams iodine injected is a derivative of the volume
injected, our opinion is that it is not the volume injected which
increases the risk of CIN, but merely the milligrams of iodine
injected.
Conclusion
Using an iodine contrast concentration of 140 mgI/mL will
lead to a significant reduction of administered iodine load,
thereby minimizing the risk for CIN, without compromising
image quality. Use of low iodine dose contrast during DSA in
PAD patients is recommended.
Acknowledgments This randomized controlled trial has been present-
ed at CIRSE in September 2015. The scientific guarantor of this publica-
tion is Prof. Dr. J.A. Reekers. The authors of this manuscript declare no
relationships with any companies, whose products or services may be
related to the subject matter of the article. This study has received funding
by GE Healthcare. GE had no influence in analysing and reporting of this
trial. No complex statistical methods were necessary for this paper. Insti-
tutional Review Board approval was obtained. Written informed consent
was obtained from all subjects (patients) in this study. Some study sub-
jects or cohorts have not been previously reported.
Methodology: prospective, randomised controlled trial, multicenter
study.
Open Access This article is distributed under the terms of the Creative
Commons Attribution-NonCommercial 4.0 International License (http://
creativecommons.org/licenses/by-nc/4.0/), which permits any noncom-
mercial use, distribution, and reproduction in any medium, provided
you give appropriate credit to the original author(s) and the source, pro-
vide a link to the Creative Commons license, and indicate if changes were
made.
References
1. Stacul F, van der Molen AJ, Reimer P et al (2011) Contrast induced
nephropathy: updated ESUR Contrast Media Safety Committee
guidelines. Eur Radiol 21:2527–2541
2. Morcos SK, Thomsen HS, Webb JA (1999) Contrast-media-induced
nephrotoxicity: a consensus report. Eur Radiol 9:1602–1613
3. Morcos SK (2005) Prevention of contrast media-induced nephro-
toxicity after angiographic procedures. J Vasc Interv Radiol 16:13–
23
4. Golshahi J, Nasri H, Gharipour M (2014) Contrast-induced ne-
phropathy; A literature review. J Nephropathol 3:51–56
5. Ukaigwe A, Karmacharya P, Mahmood M et al (2014) Meta-
analysis on efficacy of statins for prevention of contrast-induced
acute kidney injury in patients undergoing coronary angiography.
Am J Cardiol 114:1295–1302
6. Seyferth W, Dilbat G, Zeitler E (1983) Efficacy and safety of digital
subtraction angiography with special reference to contrast agents.
Cardiovasc Intervent Radiol 6:265–270
7. Naisby GP, Owen JP, Alexander TW, Cope L, Laker MF, Hamilton
PJ (1991) Transfemoral digital subtraction aortography. Are diluted
high osmolar contrast media acceptable? Acta Radiol 32:137–140
8. Ugolotti U, Larini P, Marcato C, Cusmano F, Puccianti F (1994)
Peripheral arteriography with a new nonionic agent: comparison of
iomeprol with iopamidol. Eur J Radiol 18:S77–S82
9. Ohno I, Hayashi H, Aonuma K et al (2013) Guidelines on the use of
iodinated contrast media in patients with kidney disease 2012: di-
gest version : JSN, JRS, and JCS Joint Working Group. Clin Exp
Nephrol 17:441–479
10. Moher D, Schulz KF, Altman DG (2001) The CONSORT state-
ment: revised recommendations for improving the quality of reports
of parallel-group randomised trials. Lancet 357:1191–1194
11. Radiological Society of North America Radlex Web site. Image
quality. Available via http://www.radlex.org/RID/RID10.
Accessed 20 Nov 2014
12. AdriaensenME, KockMC, Stijnen Tet al (2004) Peripheral arterial
disease: therapeutic confidence of CT versus digital subtraction
angiography and effects on additional imaging recommendations.
Radiology 233:385–391
13. Nyman U, Björk J, Aspelin P, Marenzi G (2008) Contrast medium
dose-to-GFR ratio: a measure of systemic exposure to predict
Eur Radiol (2016) 26:2446–2454 2453
contrast-induced nephropathy after percutaneous coronary inter-
vention. Acta Radiol 49:658–667
14. Kougias P, Sharath S, Barshes NR et al (2014) Impact of cumulative
intravascular contrast exposure on renal function in patients with
occlusive and aneurysmal vascular disease. J Vasc Surg 59:1644–
1650
15. Bees NR, Beese RC, Belli AM, Buckenham TM (1999) Carbon
dioxide angiography of the lower limbs: initial experience with an
automated carbon dioxide injector. Clin Radiol 54:833–838
16. Díaz LP, Pabón IP, García JA, de la Cal López MA (2000)
Assessment of CO2 arteriography in arterial occlusive disease of
the lower extremities. J Vasc Interv Radiol 11:163–169
17. Madhusudhan KS, Sharma S, Srivastava DN et al (2009)
Comparison of intra-arterial digital subtraction angiography using
carbon dioxide by ‘home made’ delivery system and conventional
iodinated contrast media in the evaluation of peripheral arterial
occlusive disease of the lower limbs. J Med Imaging Radiat
Oncol 53:40–49
18. Ho CF, Chern MS, Wu MH et al (2003) Carbon dioxide angiogra-
phy in lower limbs: a prospective comparative study with selective
iodinated contrast angiography. Kaohsiung J Med Sci 19:599–607
19. Oliva VL, Denbow N, Thérasse E et al (1999) Digital subtraction
angiography of the abdominal aorta and lower extremities: carbon
dioxide versus iodinated contrast material. J Vasc Interv Radiol 10:
723–731
20. Rolland Y, Duvauferrier R, Lucas A et al (1998) Lower limb angi-
ography: a prospective study comparing carbon dioxide with
iodinated contrast material in 30 patients. Am J Roentgenol 171:
333–337
21. Seeger JM, Self S, Harward TR, Flynn TC, Hawkins IF Jr (1993)
Carbon dioxide gas as an arterial contrast agent. Ann Surg 217:
688–697
22. Hammer FD, Goffette PP, Malaise J, Mathurin P (1999)
Gadolinium dimeglumine: an alternative contrast agent for digital
subtraction angiography. Eur Radiol 9:128–136
23. Wagner HJ, Kalinowski M, Klose KJ, Alfke H (2001) The use of
gadolinium chelates for X-ray digital subtraction angiography.
Invest Radiol 36:257–265
24. Nyman U, Elmståhl B, Leander P, Nilsson M, Golman K, Almén T
(2002) Are gadolinium-based contrast media really safer than io-
dinated media for digital subtraction angiography in patients with
azotemia? Radiology 223:311–318
25. Erley CM, Bader BD, Berger ED et al (2004) Gadolinium-based
contrast media compared with iodinated media for digital subtrac-
tion angiography in azotaemic patients. Nephrol Dial Transplant 19:
2526–2531
26. Dangas G, Iakovou I, Nikolsky E et al (2005) Contrast-induced
nephropathy after percutaneous coronary interventions in relation
to chronic kidney disease and hemodynamic variables. Am J
Cardiol 95:13–19
27. Yamamoto M, Hayashida K, Mouillet G et al (2013) Renal
function-based contrast dosing predicts acute kidney injury follow-
ing transcatheter aortic valve implantation. JACC Cardiovasc
Interv 6:479–486
2454 Eur Radiol (2016) 26:2446–2454
